One of the most touted promises of medical artificial intelligence tools is their ability to augment human clinicians’ performance by helping them interpret images such as X-rays and CT scans with greater precision to make more accurate diagnoses.
Spexis receives second extension for the publication of its 2023 annual report until July 31, 2024, releasing its unaudited financial statements and providing an update on its dispute with SPRIM. – Biotech Investments
Spexis AG / Key word(s): Annual Results 31-May-2024 / 22:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is
June 1, 2024